ChengDa Pharmaceuticals Temettü
Temettü kriter kontrolleri 2/6
ChengDa Pharmaceuticals is a dividend paying company with a current yield of 0.95% that is well covered by earnings.
Anahtar bilgiler
0.9%
Temettü verimi
-0.01%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | 0.9% |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | CN¥0.200 |
| Ödeme oranı | 44% |
Son temettü güncellemeleri
Recent updates
ChengDa Pharmaceuticals Co., Ltd.'s (SZSE:301201) 42% Price Boost Is Out Of Tune With Earnings
Oct 08
There's Reason For Concern Over ChengDa Pharmaceuticals Co., Ltd.'s (SZSE:301201) Massive 42% Price Jump
Oct 08ChengDa Pharmaceuticals (SZSE:301201) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Sep 03ChengDa Pharmaceuticals (SZSE:301201) Will Pay A Smaller Dividend Than Last Year
Jul 05Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 301201 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Büyüyen Temettü: 301201 has only been paying a dividend for 3 years, and since then payments have fallen.
Piyasaya Karşı Temettü Getirisi
| ChengDa Pharmaceuticals Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (301201) | 0.9% |
| Pazarın Alt %25'i (CN) | 0.6% |
| Pazarın En İyi %25'i (CN) | 2.2% |
| Sektör Ortalaması (Pharmaceuticals) | 1.7% |
| Analist tahmini (301201) (3 yıla kadar) | n/a |
Önemli Temettü: 301201's dividend (0.95%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Yüksek Temettü: 301201's dividend (0.95%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonably low payout ratio (43.5%), 301201's dividend payments are well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: 301201 is paying a dividend but the company has no free cash flows.